Treatment regimens often evolve without strong scientific evidence of their benefits and drawbacks, particularly in comparison to other drugs or approaches.Now Duke Medicine is participating in a large national initiative aiming to fill in that missing information.In separate articles published in the Annals of Internal Medicine, teams led by the Duke Clinical Research Institute detailed the research priorities necessary to address gaps in knowledge about two conditions - bipolar disorder among adolescents and early breast tumors in women.
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment